Vanguard Group’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History

Vanguard Group’s Portfolio TRIV Stock Details TRIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-132,503	Closed	-$882K	–	4189
2015 Q4	$882K	Buy	132,503 +4,765	+4%	+$31.6K	﹤0.01%	3662
2015 Q3	$639K	Buy	127,738 +4,948	+4%	+$26.6K	﹤0.01%	3775
2015 Q2	$657K	Sell	122,790 -4,445	-3%	-$31.5K	﹤0.01%	3786
2015 Q1	$1.33M	Buy	127,235 +11,238	+10%	+$116K	﹤0.01%	3549
2014 Q4	$1.46M	Buy	115,997 +55,439	+92%	+$756K	﹤0.01%	3394
2014 Q3	$877K	Buy	60,558 +5,496	+10%	+$79.8K	﹤0.01%	3551
2014 Q2	$857K	Buy	+55,062	New	+$836K	﹤0.01%	3523

Vanguard Group's TRIV Position: Q1 2016 in Review

Vanguard Group sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q1 2016, closing a stake of 132,503 shares — an estimated $882K sold.

Vanguard Group first reported a position in TRIV in Q2 2014 and held it in 7 quarters. The position peaked at $1.46M in Q4 2014. 0 funds tracked by Wall St. Rank hold TRIV as of Q1 2016.

Vanguard Group reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q1 2016 after selling out during the quarter.
Vanguard Group sold 132,503 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q1 2016, an estimated $882K.
Vanguard Group first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q2 2014 and held it in 7 quarters.
Vanguard Group's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $1.46M in Q4 2014.
0 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q1 2016.

Based on Vanguard Group's 13F filing for Q1 2016, filed 13 May 2016.